Several significant new injectable cancer drugs are now hitting the market
July 1996
Several significant new injectable cancer drugs are now hitting the market...with more on the way. The FDA is accelerating approval of important cancer drugs...similar to AIDS drugs.
Lilly is now marketing Gemzar (GEM-zar, gemcitabine), the first new drug for advanced pancreatic cancer in 30 years.
It's an alternative to 5-fluorouracil and reduces pain better.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote